Nature’s Sunshine Products, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Details)

Basis of Presentation (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended				3 Months Ended		9 Months Ended			3 Months Ended					9 Months Ended						3 Months Ended		9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2014 Subsidiary in Venezuela	Sep. 30, 2013 Subsidiary in Venezuela	Sep. 30, 2014 Subsidiary in Venezuela	Sep. 30, 2013 Subsidiary in Venezuela	Dec. 31, 2013 Subsidiary in Venezuela	Dec. 31, 2014 Subsidiary in Venezuela Forecast Minimum	Dec. 31, 2014 Subsidiary in Venezuela Forecast Maximum	Dec. 31, 2013 Subsidiary in Venezuela Currency Control Agency [Member]	Feb. 11, 2013 Subsidiary in Venezuela Currency Control Agency [Member]	Dec. 31, 2013 Subsidiary in Venezuela Currency Control Agency [Member] Medicinal Products [Member]	Sep. 30, 2014 Subsidiary in Venezuela First Complementary System For Foreign Currency Administration [Member]	Jan. 24, 2014 Subsidiary in Venezuela First Complementary System For Foreign Currency Administration [Member]	Dec. 31, 2013 Subsidiary in Venezuela First Complementary System For Foreign Currency Administration [Member]	Dec. 31, 2013 Subsidiary in Venezuela First Complementary System For Foreign Currency Administration [Member] Other Beneficial Products [Member]	Jan. 24, 2014 Subsidiary in Venezuela New Currency Control Agency [Member]	Sep. 30, 2014 Subsidiary in Venezuela Second Complementary System For Foreign Currency Administration [Member]	Sep. 30, 2014 Belarusian subsidiary	Sep. 30, 2013 Belarusian subsidiary	Sep. 30, 2014 Belarusian subsidiary	Sep. 30, 2013 Belarusian subsidiary
Classification of Venezuela and Belarus as a Highly Inflationary Economy and Devaluation of Its Currencies
Exchange rate												6.3	6.3	6.3		11.3	11.3	11.3	6.3	50.0
Foreign exchange loss from a re-measurement of assets and liabilities using official exchange rates															$ 1,224
Impairment charge	2,947						2,947
Net sales revenue as a percent of consolidated net sales revenue					1.50%	2.20%	1.80%	2.10%													2.10%	2.10%	2.30%	2.10%
Cash and cash equivalents	70,456	77,247	76,623	79,241	795		795		3,922
Net assets					804		804		5,721
Property, Plant and Equipment, Net	45,373	32,022			0		0		3,207
Charge related to exit costs										$ 600	$ 800

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.

+ References + Details

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References + Details

- Definition

The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).

+ References + Details